LifeLens Technologies

LifeLens Technologies secures FDA 510(k) clearance for additional indications on its **LifeLens Physiological Monitor**, expanding the wearable device’s capabilities in vital sign monitoring. The update follows the company’s prior FDA approval for its physiological tracking technology, reinforcing its position in remote health diagnostics. No specific new features or customer deployments are detailed in the announcement.

Jul 2026PR NewswireNews article

LifeLens Technologies begins a clinical study to evaluate its wearable medical device designed for sleep assessment. The trial aims to assess the device’s accuracy and performance in monitoring sleep patterns. LifeLens specializes in health-tech solutions, focusing on non-invasive diagnostic tools.

Jul 2026LifeLensNews article

LifeLens Technologies enrolls first patients in its **Physiologic Performance Monitoring Optimization (PPMO) study**, a clinical trial evaluating real-time performance tracking. The company opens the **LifeLens Performance Center** to support research integrating wearable sensors and AI-driven analytics. This marks a key step toward optimizing athletic and cognitive performance through data-driven insights.

Jun 2026LifeLensNews article

4ID demonstrates a new triage and evacuation technology for soldiers in a simulated **LSCO (Large-Scale Casualty Operation) environment**. The system integrates real-time physiological monitoring and automated decision support to improve battlefield medical response. LifeLens Technologies, Inc. also receives **FDA 510(k) clearance** for its Wearable Physiological Monitoring system, expanding its applications beyond military use.

Feb 2026LifeLensNews article